Klinker, K.P.; Hidayat, L.K.; Wenzler, E.; Balada-Llasat, J.-M.; Motyl, M.; DeRyke, C.A.; Bauer, K.A.
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics 2022, 11, 660.
https://doi.org/10.3390/antibiotics11050660
AMA Style
Klinker KP, Hidayat LK, Wenzler E, Balada-Llasat J-M, Motyl M, DeRyke CA, Bauer KA.
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics. 2022; 11(5):660.
https://doi.org/10.3390/antibiotics11050660
Chicago/Turabian Style
Klinker, Kenneth P., Levita K. Hidayat, Eric Wenzler, Joan-Miquel Balada-Llasat, Mary Motyl, C. Andrew DeRyke, and Karri A. Bauer.
2022. "Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States" Antibiotics 11, no. 5: 660.
https://doi.org/10.3390/antibiotics11050660
APA Style
Klinker, K. P., Hidayat, L. K., Wenzler, E., Balada-Llasat, J.-M., Motyl, M., DeRyke, C. A., & Bauer, K. A.
(2022). Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics, 11(5), 660.
https://doi.org/10.3390/antibiotics11050660
